In focus · trending topic

Exclusive Option Agreement

1 stories · following the connections

Amarantus Enters into Exclusive Option Agreement with Leipzig University to License IP Covering Alzheimer's Blood Diagnostic LymPro Test 2.0 Blood Test vs. Amyloid PET

By Nasdaq OMXMay 4, 2018, 12:45 PM UTC